Biotechnology and Medical Research (TRBC)

UniQure gene therapy shows rise in blood-clotting protein levels

UniQure gene therapy shows rise in blood-clotting protein levels

Published 08/02/2019

(Reuters) - Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in [more…]

Gene therapy stocks plunge after poor trial data

Gene therapy stocks plunge after poor trial data

Published 07/02/2019

(Reuters) - Shares of U.S. gene therapy companies sank on Thursday after drugs developed by two small firms failed to show promise in separate clinical [more…]

Chinese police begin new probe into expired vaccines

Chinese police begin new probe into expired vaccines

Published 14/01/2019

SHANGHAI (Reuters) - Police in China’s eastern province of Jiangsu have begun an investigation after at least 145 children received expired polio vaccines, the Global [more…]

Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

Published 11/01/2019

(Reuters) - Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, [more…]

U.S. FDA approves Stemline Therapeutics’ rare blood disease treatment

U.S. FDA approves Stemline Therapeutics’ rare blood disease treatment

Published 21/12/2018

(Reuters) - The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc’s Elzonris for the treatment of a rare blood disease in adults [more…]

Alexion wins early U.S. approval for rare blood disorder drug

Alexion wins early U.S. approval for rare blood disorder drug

Published 21/12/2018

(Reuters) - The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc’s rare blood disorder drug Ultomiris, an early backing that also solidifies [more…]

Two of a kind: China’s first pet cloning service duplicates star pooch

Two of a kind: China’s first pet cloning service duplicates star pooch

Published 19/12/2018

BEIJING (Reuters) - Juice is a one-foot tall canine wonder who has starred in dozens of Chinese film and television productions. As he gets older [more…]

Gilead Sciences snares Roche veteran O’Day as CEO

Gilead Sciences snares Roche veteran O’Day as CEO

Published 10/12/2018

(Reuters) - Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill [more…]

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

Published 03/12/2018

LONDON (Reuters) - GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new [more…]

RedHill Biopharma’s antibiotic succeeds in late-stage study

RedHill Biopharma’s antibiotic succeeds in late-stage study

Published 03/12/2018

(Reuters) - Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients [more…]